MSH|^~\&|ADM|ARH|||201910211139||ADT^A03|4086866|D|2.2|||AL|NE
EVN|A03|201910211139||||201910211139
PID|1|FHATVIG0001836|AB00007094|AB7097|PCSTEST^RT||19760216|M|||403-1125 BRAID ST^^NEW WESTMINSTER^BC^V3K 4L5|||||||AB002128/17|
PV1|1|I|AB-2BAKER^AB2B-FLO^E|UE|||OEDOCN^Oedoc^Nancytrain^^^^MD^^^^^^XX|||MEDS||||||||IN||||||||||||||||||DISCHARGED TO ACUTE FACILITY|||ARH|||||201802160738|201910211139
PV2||W^Ward|
OBX|1|TX|ADM CURRES^Residing at current add. since (DD/MM/YY)^ADM||20150831||||||F
OBX|2|CE|ADM IDSOUR^SOURCE OF ID^ADM||BCSWP^BC Services With Photo||||||F
OBX|3|CE|ADM MDRO2^Canada in the last 12 months?^ADM||N^NO||||||F
OBX|4|CE|ADM MDRO4^or Bangladesh in the last 12 months?^ADM||N^NO||||||F
OBX|5|CE|ADM MRSA2^correctional/shelter in the last 6 months?^ADM||N^NO||||||F
OBX|6|TX|AcNEOC0101^Skin care performed^ADM||Y||||||F
OBX|7|TX|AdBIRTH010^Expected date of delivery^ADM||20181123||||||F
OBX|8|TX|AdCOMDIF00^Communication difficulties^ADM||Y||||||F
OBX|9|TX|AdINTNEE00^Interpreter needed^ADM||Y||||||F
OBX|10|TX|AdPRLANG00^Primary language spoken^ADM||Japanese||||||F
OBX|11|CE|AdRC000400^Outreach referral criteria^ADM||1^Ward staff concerned~2^O2 sat less than 90%~11^RR less than 8/min||||||F
OBX|12|TX|AdRC000500^Outreach referral criteria other^ADM||referral other||||||F
OBX|13|CE|Ca00001500^Pulse strength^ADM||1^Doppler||||||F
OBX|14|CE|Ca00001600^Capillary refill^ADM||4^Greater/Equal to 5 sec||||||F
OBX|15|TX|CaCASYAN03^Cardiovascular system analysis^ADM||cardio||||||F
OBX|16|CE|CaCCHD0131^Screening number^ADM||1^1||||||F
OBX|17|TX|CaCCHD0140^Pulse oximetry right hand^ADM||56||||||F
OBX|18|TX|CaCCHD0150^Pulse oximetry either foot^ADM||89||||||F
OBX|19|TX|CaCCHD0160^Difference between pulse oximetry^ADM||33||||||F
OBX|20|TX|CaCCHD0172^Screening outcome^ADM||Fail||||||F
OBX|21|CE|CaCWCOLO01^CWMS colour^ADM||4^Mottled||||||F
OBX|22|TX|EcPEDGLY00^Weight used for insulin dosing^ADM||3.200||||||F
OBX|23|TX|EcPEDGLY10^Insulin infusion dose^ADM||41.3||||||F
OBX|24|CE|EcPEDGLY20^Insulin infusion concentration^ADM||2^Other||||||F
OBX|25|TX|EcPEDGLY30^Insulin infusion concentration other^ADM||66.0||||||F
OBX|26|TX|EcPEDGLY40^Infusion rate^ADM||2.0||||||F
OBX|27|TX|GiGISYAN02^Gastrointestinal system^ADM||GI||||||F
OBX|28|TX|GuGUSYAN02^Genitourinary system^ADM||GU||||||F
OBX|29|CE|He00001200^Nasal complaints^ADM||2^Foreign body~6^Epistaxis||||||F
OBX|30|CE|He00001500^Oral location modifier^ADM||1^Right~3^Upper||||||F
OBX|31|CE|He00001600^Oral location^ADM||1^Lip||||||F
OBX|32|CE|He00001700^Oral condition^ADM||14^Inflamed~18^Smooth||||||F
OBX|33|CE|HeEA000100^Ears location modifier^ADM||2^Right||||||F
OBX|34|CE|HeEA000300^Ears discharge description^ADM||1^Clear||||||F
OBX|35|CE|HeEARCOM00^Ear complaints^ADM||2^Foreign body||||||F
OBX|36|CE|HeEY000101^Affected eye(s)^ADM||2^Right||||||F
OBX|37|CE|HeHEBEHA01^Neurological findings current behaviour^ADM||1^Lethargic~4^Sedated||||||F
OBX|38|CE|HeNO000301^Nares^ADM||1^Right||||||F
OBX|39|CE|HeNO000601^Nose discharge consistency^ADM||2^Thick||||||F
OBX|40|CE|HeNO000701^Nasal discharge description^ADM||2^Serous||||||F
OBX|41|CE|HeNOSEDR00^Nose drainage amount^ADM||2^Scant||||||F
OBX|42|CE|HeSL013001^Oral cavity hygiene^ADM||4^Poor||||||F
OBX|43|CE|HeSL013100^Oral cavity dentition^ADM||2^Edentulous~11^Some missing~12^Sparse||||||F
OBX|44|TX|INSKCLIC02^Skin integrity comments^ADM||integrity comments||||||F
OBX|45|CE|InEDEMAS00^Edema severity^ADM||4^+4||||||F
OBX|46|CE|InEDEMLB01^Edema location^ADM||13^Up to ankle||||||F
OBX|47|CE|InEDEMLM00^Edema location modifier^ADM||1^Bilateral||||||F
OBX|48|CE|InEDEMTP00^Edema type^ADM||2^Non-pitting||||||F
OBX|49|TX|IoNICUIN20^Location^ADM||Right arm||||||F
OBX|50|TX|IoNICUIN30^Intake, IV Amount^ADM||900.00||||||F
OBX|51|CE|IoSOLUMA00^Solution^ADM||1^NS||||||F
OBX|52|CE|IvININST00^Insulin infusion type^ADM||1^Regular||||||F
OBX|53|TX|IvRATE0000^Rate^ADM||125.00||||||F
OBX|54|CE|MoADAPTV00^Adaptive aids^ADM||7^Tub transfer bench~10^Shower stool||||||F
OBX|55|CE|MoAMASST00^Ambulation assistance required^ADM||2^2 person||||||F
OBX|56|CE|MoAMBACT00^Ambulation activity^ADM||2^Ambulation in hall||||||F
OBX|57|TX|MoAMDIST00^Ambulation distance^ADM||5.0||||||F
OBX|58|TX|MoAMDIST01^Ambulation distance^ADM||82.0||||||F
OBX|59|TX|MoAMGAIT00^Ambulation gait comment^ADM||Ambu comments||||||F
OBX|60|CE|MoAMGASZ00^Ambulation size of gait aid used^ADM||4^Bariatric||||||F
OBX|61|CE|MoAMGTAD01^Ambulation gait aid^ADM||11^4 wheeled walker||||||F
OBX|62|CE|MoAMLFNC00^Ambulation level of function^ADM||7^Maximal assist||||||F
OBX|63|CE|MoBCASST00^Bed to chair transfer assistance required^ADM||2^2 person||||||F
OBX|64|TX|MoBCCMTS00^Bed to chair transfer comment^ADM||Transfer comments||||||F
OBX|65|CE|MoBCEQPT02^Transfer equipment^ADM||2^Gutter crutch||||||F
OBX|66|CE|MoBCLFNC00^Bed to chair transfer level of function^ADM||2^Supervision||||||F
OBX|67|CE|MoBCTFTO01^Transfer to^ADM||2^Chair||||||F
OBX|68|CE|MoBCTTFR01^Transfer from^ADM||4^Toilet||||||F
OBX|69|CE|MoDSASST00^Dynamic sitting assistance required^ADM||2^2 person||||||F
OBX|70|TX|MoDSCMTS00^Dynamic sitting comment^ADM||Dynamic comments||||||F
OBX|71|CE|MoDSLFNC00^Dynamic sitting level of function^ADM||1^Complete independence||||||F
OBX|72|CE|MoDSTAST00^Dynamic standing assistance required^ADM||2^2 person||||||F
OBX|73|TX|MoDSTCMT00^Dynamic standing comment^ADM||Dynamic comments||||||F
OBX|74|CE|MoDSTEQP01^Dynamic standing equipment^ADM||11^4 wheeled walker||||||F
OBX|75|CE|MoDSTLFN00^Dynamic standing level of function^ADM||3^Moderate assist||||||F
OBX|76|CE|MoMOVEDR00^Movement direction^ADM||1^Moving up in bed||||||F
OBX|77|TX|MoRPASDO00^Repositioning in bed assistive equipment other^ADM||equip other||||||F
OBX|78|CE|MoRPASDV02^Assistive equipment^ADM||2^Bed rail~6^Tri turn sling||||||F
OBX|79|CE|MoRPASST00^Repositioning in bed assistance required^ADM||1^1 person||||||F
OBX|80|TX|MoRPCMTS00^Repositioning in bed comment^ADM||Bed mob comments||||||F
OBX|81|CE|MoRPLFNC00^Repositioning in bed level of function^ADM||2^Supervision||||||F
OBX|82|CE|MoSASGTP00^Stairs ascending gait pattern^ADM||2^Non-reciprocal||||||F
OBX|83|CE|MoSDSGTP00^Stairs descending gait pattern^ADM||3^Leading right||||||F
OBX|84|CE|MoSRASST00^Stairs assistance required^ADM||2^2 person||||||F
OBX|85|CE|MoSRGTAD01^Stairs gait aid^ADM||2^Quad cane||||||F
OBX|86|CE|MoSRHRAL00^Stairs hand rail used^ADM||2^Left going up||||||F
OBX|87|CE|MoSRLFNC00^Stairs level of function^ADM||1^Complete independence||||||F
OBX|88|TX|MoSRSTEP00^Stairs number of steps^ADM||Stairs number||||||F
OBX|89|CE|MoSSASST00^Static sitting assistance required^ADM||1^1 person||||||F
OBX|90|TX|MoSSCMTS00^Static sitting comment^ADM||Static commments||||||F
OBX|91|CE|MoSSLFNC00^Static sitting level of function^ADM||1^Complete independence||||||F
OBX|92|CE|MoSSTAST00^Static standing assistance required^ADM||2^2 person||||||F
OBX|93|TX|MoSSTCMT00^Static standing comment^ADM||Static stand  comments||||||F
OBX|94|CE|MoSSTEQP01^Static standing equipment^ADM||12^Ceiling lift||||||F
OBX|95|CE|MoSSTLFN00^Static standing level of function^ADM||4^Total assist||||||F
OBX|96|CE|MoSTSAST00^Sit to stand assistance required^ADM||2^2 person||||||F
OBX|97|TX|MoSTSCMT01^Sit to stand comments^ADM||sit to stand comments||||||F
OBX|98|CE|MoSTSEQP01^Sit to stand equipment^ADM||2^Stand assist device||||||F
OBX|99|CE|MoSTSLFN00^Sit to stand level of function^ADM||4^Total assist||||||F
OBX|100|CE|Ne00004000^Sensory limb location^ADM||3^Right lower limb||||||F
OBX|101|CE|Ne00004100^Sensory type^ADM||1^Light touch||||||F
OBX|102|CE|Ne00004200^Sensory nerve location^ADM||5^Peroneal||||||F
OBX|103|CE|Ne00004300^Sensation^ADM||2^Tingling||||||F
OBX|104|TX|NeHEBEOT00^Neurological findings current behaviour other^ADM||current state other||||||F
OBX|105|CE|NeLECONS01^Level of consciousness^ADM||6^Sedated||||||F
OBX|106|TX|NeNESYAN02^Neurological system analysis^ADM||neuro||||||F
OBX|107|CE|NeNICUN010^Location^ADM||3^Right lower limb||||||F
OBX|108|CE|NeNICUN020^Artery^ADM||3^Posterior tibial||||||F
OBX|109|CE|NeVIPRVP00^Patient report of vision problems^ADM||4^Blurred vision~5^Decreased acuity||||||F
OBX|110|TX|OhLABMED00^Medications and labs^ADM||labs/meds||||||F
OBX|111|TX|OhPROCTO00^Patient's tolerance of procedure comment^ADM||tolerance||||||F
OBX|112|TX|PhHEMOCN00^Hemodynamic concentration^ADM||2mg||||||F
OBX|113|TX|PhHEMODS01^Hemodynamic dose^ADM||10.000||||||F
OBX|114|CE|PhHEMOIN01^Hemodynamic infusion^ADM||1^Amiodarone||||||F
OBX|115|TX|PhHEMORT02^Hemodynamic rate^ADM||25.000||||||F
OBX|116|CE|PhINFDOS00^Hemodynamic infusion dosage units^ADM||2^mg/min||||||F
OBX|117|TX|PsCEL00000^Communication English literacy^ADM||Y||||||F
OBX|118|TX|PsCLB00000^Communication language barrier^ADM||Y||||||F
OBX|119|TX|PsCOMPRL00^Communication primary language^ADM||Polish||||||F
OBX|120|CE|PsGAD7AF02^Afraid that something bad is going to happen^ADM||2^No||||||F
OBX|121|CE|PsGD000001^Basically satisfied with life^ADM||1^Yes||||||F
OBX|122|CE|PsGD000101^Dropped many activities and interests^ADM||2^No||||||F
OBX|123|CE|PsGD000201^Feel that life is empty^ADM||1^Yes||||||F
OBX|124|CE|PsGD000301^Often get bored^ADM||1^Yes||||||F
OBX|125|CE|PsGD000401^In good spirits most of the time^ADM||2^No||||||F
OBX|126|CE|PsGD000602^Feel happy most of the time^ADM||2^No||||||F
OBX|127|CE|PsGD000701^Often feel helpless^ADM||2^No||||||F
OBX|128|CE|PsGD000801^Prefer staying at home to going out and doing things^ADM||1^Yes||||||F
OBX|129|CE|PsGD000901^Feel more problems with memory than most people^ADM||2^No||||||F
OBX|130|CE|PsGD001001^Think it is wonderful to be alive now^ADM||2^No||||||F
OBX|131|CE|PsGD001101^Feel pretty worthless right now^ADM||2^No||||||F
OBX|132|CE|PsGD001201^Feel full of energy^ADM||2^No||||||F
OBX|133|CE|PsGD001301^Feel situation is hopeless^ADM||2^No||||||F
OBX|134|CE|PsGD001401^Think that most people are better off than self^ADM||1^Yes||||||F
OBX|135|TX|PsGD001500^GDS-SF score^ADM||8||||||F
OBX|136|TX|ReABNORM00^Abnormal findings comments^ADM||commentsz||||||F
OBX|137|TX|ReAENTRY00^Air entry adequate throughout^ADM||Y||||||F
OBX|138|CE|ReAUAIRE01^Air entry^ADM||4^Diminished||||||F
OBX|139|CE|ReAUBTHS02^Breath sounds^ADM||7^Bronchial~8^Coarse~9^Stridor||||||F
OBX|140|CE|ReAULOCT00^Auscultation location^ADM||5^Right base||||||F
OBX|141|CE|ReAULOMO00^Auscultation location modifier^ADM||1^Anterior||||||F
OBX|142|TX|ReAWSDCC01^Securement device checked or changed^ADM||Y||||||F
OBX|143|TX|ReBCLEAR00^Breath sounds clear throughout^ADM||N||||||F
OBX|144|TX|ReBR001300^Bronchoscopy lidocaine spray number of applications^ADM||2||||||F
OBX|145|TX|ReBRESOU00^Breath sounds other^ADM||breath sounds other||||||F
OBX|146|CE|ReCGDESC01^Cough description^ADM||2^Congested||||||F
OBX|147|TX|ReCGDESO00^Cough description other^ADM||desc other||||||F
OBX|148|TX|ReCGPROD00^Cough productive^ADM||Y||||||F
OBX|149|CE|ReCGSTGH00^Cough strength^ADM||3^Weak||||||F
OBX|150|CE|ReCOLMET03^Suctioning method^ADM||1^Closed/Inline suction~2^Open catheter~3^Yankauer||||||F
OBX|151|TX|ReDESCOM00^Description other^ADM||descrip other||||||F
OBX|152|TX|ReENDDAT00^Endotracheal removal date^ADM||20180216||||||F
OBX|153|TX|ReENDTIM00^Endotracheal removal time^ADM||0951||||||F
OBX|154|CE|ReENTRTU00^ETT tube location^ADM||1^Oral||||||F
OBX|155|CE|ReETINME01^Intubation method^ADM||1^Direct laryngoscopy||||||F
OBX|156|TX|ReETINNA01^Number of intubation attempts^ADM||2||||||F
OBX|157|CE|ReETINPC00^Intubation position confirmation^ADM||1^Auscultation~2^Bilateral chest expansion~3^Colorimetric CO2 detector~4^End-tidal CO2||||||F
OBX|158|TX|ReETINPC10^Intubation position confirmation other^ADM||postion confrimation||||||F
OBX|159|CE|ReETINPR02^Reason for intubation^ADM||2^Oxygenation failure||||||F
OBX|160|TX|ReETINPX01^Intubation location confirmation via X-ray^ADM||Y||||||F
OBX|161|TX|ReETINSD01^Intubation securement device used^ADM||securement device||||||F
OBX|162|TX|ReETINTA00^Intubation tube advanced^ADM||3.0||||||F
OBX|163|TX|ReETINTW00^Intubation tube withdrawn^ADM||6.0||||||F
OBX|164|CE|ReETTBSZ02^Endotracheal tube size^ADM||7^2.5 mm||||||F
OBX|165|CE|ReETTBTY03^Endotracheal tube type^ADM||2^Uncuffed||||||F
OBX|166|TX|ReEVPRRE01^Events leading up to referral^ADM||events leading up||||||F
OBX|167|CE|ReEXTREA02^Reason for extubation^ADM||1^Elective||||||F
OBX|168|TX|ReEXTUBA01^Extubation comments^ADM||extubation||||||F
OBX|169|TX|ReEXVEPA01^Volume epinephrine administered^ADM||2.6||||||F
OBX|170|TX|ReHFBPWC02^High flow based on patient weight^ADM||3.00||||||F
OBX|171|TX|ReHIPRAL02^High inspiratory pressure alarm^ADM||5||||||F
OBX|172|TX|ReHUMTEM00^Humidifier temperature^ADM||39.0||||||F
OBX|173|TX|ReIN000100^Correct intubation tube position as confirmed by X-ray^ADM||23.0||||||F
OBX|174|TX|ReINPOTN01^Initial position at teeth/nares^ADM||29.0||||||F
OBX|175|TX|ReINSDAT00^Endotracheal tube insertion date^ADM||20180216||||||F
OBX|176|TX|ReINSTIM00^Endotracheal tube insertion time^ADM||0800||||||F
OBX|177|CE|ReINTUBA01^Intubated by^ADM||2^Respiratory Therapist||||||F
OBX|178|TX|ReINTUBC00^Other intubation comments^ADM||intubation comments||||||F
OBX|179|TX|ReLOINPR02^Low inspiratory pressure alarm^ADM||9||||||F
OBX|180|CE|ReNACAIT02^Type of heated high flow system^ADM||2^Neonatal||||||F
OBX|181|CE|ReNACARE03^Primary reason for initiating heated high flow^ADM||1^High FiO2 requirements||||||F
OBX|182|TX|ReNEEQSC06^Safety equipment present and checked^ADM||Y||||||F
OBX|183|TX|ReNETTSU01^Suction depth^ADM||suction depth`||||||F
OBX|184|TX|ReNETTSW01^Suction depth warning^ADM||depth warning||||||F
OBX|185|TX|ReNIBONT00^Neonatal non-invasive ventilation bonnet colour and size^ADM||4||||||F
OBX|186|TX|ReNICVEN01^Birth weight tidal volume in mL/kg^ADM||5.0||||||F
OBX|187|TX|ReNICVEN11^Current weight tidal volume in mL/kg^ADM||2.0||||||F
OBX|188|TX|ReNICVEN20^Peak inspiratory pressure (set)^ADM||22||||||F
OBX|189|TX|ReNICVEN30^Peak inspiratory pressure (measured)^ADM||22||||||F
OBX|190|TX|ReNICVEN90^High minute volume alarm^ADM||2||||||F
OBX|191|CE|ReNIMASK01^Neonate mask size^ADM||2^Medium||||||F
OBX|192|TX|ReNIVEDD00^Non-invasive ventilation discontinuation date^ADM||20180216||||||F
OBX|193|TX|ReNIVEDT00^Non-invasive ventilation discontinuation time^ADM||0931||||||F
OBX|194|TX|ReNIVENT05^Pressure high - flow rate^ADM||3||||||F
OBX|195|TX|ReNIVENT06^Pressure low - flow rate^ADM||6||||||F
OBX|196|TX|ReNIVENT07^Base flow^ADM||8||||||F
OBX|197|TX|ReNIVENT08^Transcutaneous PCO2^ADM||63||||||F
OBX|198|CE|ReNIVENT10^Transcutaneous PCO2 site^ADM||4^Buttocks||||||F
OBX|199|TX|ReNIVENT11^Transcutaneous PCO2 site changed^ADM||Y||||||F
OBX|200|TX|ReNIVENT12^Transcutaneous PCO2 site skin intact^ADM||Y||||||F
OBX|201|TX|ReNIVENT13^Transcutaneous PCO2 temperature^ADM||40.0||||||F
OBX|202|TX|ReNIVENT14^Transcutaneous PCO2 alarms checked^ADM||Y||||||F
OBX|203|TX|ReNIVENT15^Transcutaneous PCO2 sensor remembraned^ADM||Y||||||F
OBX|204|CE|ReNIVENT20^Transcutaneous PCO2 site modifier^ADM||2^Right medial||||||F
OBX|205|TX|ReNIVENT30^Pressure high (set)^ADM||13.0||||||F
OBX|206|TX|ReNIVENT40^Pressure high (measured)^ADM||6.0||||||F
OBX|207|TX|ReNIVENT50^Pressure low/CPAP (set)^ADM||5.0||||||F
OBX|208|TX|ReNIVENT60^Pressure low/CPAP (measured)^ADM||9.0||||||F
OBX|209|TX|ReNIVENT70^Pressure support^ADM||1.0||||||F
OBX|210|TX|ReNOINDA01^Non-invasive ventilation initiation date^ADM||20180216||||||F
OBX|211|TX|ReNOIVTI01^Non-invasive ventilation initiation time^ADM||0929||||||F
OBX|212|CE|ReNPRONG00^Neonatal prong size^ADM||2^Small||||||F
OBX|213|CE|ReNRDISI02^Respiratory distress indicators^ADM||5^Intercostal indrawing~11^Substernal indrawing~16^Sternal indrawing||||||F
OBX|214|CE|ReNRWOBR01^Neonatal respiratory work of breathing^ADM||3^Moderate||||||F
OBX|215|TX|ReO2000100^Oxygen L/minute to maintain SpO2 greater than 96%^ADM||0.21||||||F
OBX|216|CE|ReOSTAIR00^PRAM O2 saturation on room air^ADM||2^92-94% (1)||||||F
OBX|217|TX|ReOTASCO00^Other assessment comments^ADM||general comments||||||F
OBX|218|TX|ReOTVECO00^Other ventilation comments^ADM||vent comments||||||F
OBX|219|TX|ReOVPLAN00^Overall plan^ADM||ax comments||||||F
OBX|220|CE|ReOXYTHE05^Oxygen therapy delivery method^ADM||1^Room air||||||F
OBX|221|CE|ReOXYUOM00^Oxygen units of measure^ADM||2^mL/min||||||F
OBX|222|TX|RePEDAST00^Discharge criteria: PRAM score 0 - 3^ADM||Y||||||F
OBX|223|TX|RePEDAST01^Discharge criteria: SpO2 greater than 92% on room air^ADM||N||||||F
OBX|224|TX|RePEDAST02^Discharge criteria: Expiratory wheeze only^ADM||N||||||F
OBX|225|TX|RePEDAST03^Discharge criteria: No retractions^ADM||Y||||||F
OBX|226|TX|RePEDAST04^Discharge criteria: 1 hour from last inhaled treatment^ADM||N||||||F
OBX|227|TX|RePEDAST05^Discharge criteria: 2hrs post Tx if initial score 4 or above^ADM||N||||||F
OBX|228|TX|RePEDAST06^Discharge planning: Discharge instructions printed and given^ADM||N||||||F
OBX|229|TX|RePEDAST07^Discharge planning: Prescription given^ADM||N||||||F
OBX|230|TX|RePEDAST08^Discharge planning: Patient teaching completed^ADM||N||||||F
OBX|231|CE|RePEDAST09^Discharge planning: Device recommendations^ADM||1^MDI/Spacer with mask||||||F
OBX|232|TX|RePEDAST10^Discharge planning: Referral to asthma clinic^ADM||N||||||F
OBX|233|TX|RePEDAST11^Other pediatric asthma comments^ADM||ped comments||||||F
OBX|234|TX|RePEDAST12^Discharge criteria met^ADM||Y||||||F
OBX|235|TX|RePEEP0001^T-piece resuscitator present and checked^ADM||Y||||||F
OBX|236|CE|RePHASE000^Phase^ADM||1^Inspiration||||||F
OBX|237|TX|RePHASE010^Phase other^ADM||phase otgher||||||F
OBX|238|CE|RePRAMAE01^PRAM air entry^ADM||2^Decreased at bases (1)||||||F
OBX|239|TX|RePRAMSC02^PRAM score total^ADM||3||||||F
OBX|240|CE|RePRAMSI00^PRAM suprasternal retraction^ADM||1^Absent (0)||||||F
OBX|241|CE|RePRAMSR00^PRAM scalene muscle contraction^ADM||1^Absent (0)||||||F
OBX|242|CE|RePRAMWH01^PRAM wheezing^ADM||2^Expiratory only (1)||||||F
OBX|243|TX|ReRCNXRY00^Most recent chest x-ray^ADM||20180216||||||F
OBX|244|TX|ReRECHEO00^Chest expansion other^ADM||chest expansion||||||F
OBX|245|CE|ReRECHEX01^Chest expansion^ADM||4^Paradoxical~5^Left greater than right||||||F
OBX|246|TX|ReREDISC00^Respiratory distress indicators comment^ADM||resp comments||||||F
OBX|247|TX|ReREDISO00^Respiratory distress indicators other^ADM||resp other||||||F
OBX|248|CE|ReREDPTH00^Respiratory depth^ADM||2^Shallow||||||F
OBX|249|TX|ReREGNCM01^Other non-invasive ventilation comments^ADM||vent comments||||||F
OBX|250|TX|ReREMECO01^Other respiratory medication comments^ADM||resp med comments||||||F
OBX|251|CE|ReREPTRN02^Respiratory pattern^ADM||2^Bradypneic||||||F
OBX|252|CE|ReRERTCO01^RT consult type^ADM||1^Initial referral||||||F
OBX|253|TX|ReRESYAN02^Respiratory system^ADM||resp||||||F
OBX|254|CE|ReSCAMNT00^Secretions amount^ADM||3^Moderate||||||F
OBX|255|CE|ReSCCOLR00^Secretions colour^ADM||7^Green||||||F
OBX|256|CE|ReSCDESC02^Secretions description^ADM||2^Sanguineous/bloody~3^Creamy~4^Thick||||||F
OBX|257|CE|ReSE000102^Secretions source^ADM||5^Nasopharyngeal||||||F
OBX|258|TX|ReSECCOM00^Secretions comments^ADM||secretion s||||||F
OBX|259|TX|ReSECMET00^Secretions collection method other^ADM||method otehr||||||F
OBX|260|CE|ReSECOMT00^Secretions collection method^ADM||2^Expectorated||||||F
OBX|261|CE|ReSFADMT02^Surfactant route of administration^ADM||1^Multi access catheter||||||F
OBX|262|TX|ReSFAMNT00^Surfactant amount^ADM||5||||||F
OBX|263|TX|ReSFDOSE01^Surfactant treatment number^ADM||3||||||F
OBX|264|TX|ReSFLOTN01^Surfactant lot number^ADM||236||||||F
OBX|265|TX|ReSTDRPR00^Stridor present^ADM||Y||||||F
OBX|266|TX|ReTORERA01^Respiratory rate (total)^ADM||63||||||F
OBX|267|TX|ReVE000202^Ventilator type^ADM||Vent type||||||F
OBX|268|CE|ReVE000303^Ventilator mode^ADM||11^PSV+VG||||||F
OBX|269|TX|ReVE000500^Adult ventilation ventilator number^ADM||5||||||F
OBX|270|TX|ReVE000602^Ventilator change due date^ADM||18 Mar 2018||||||F
OBX|271|TX|ReVE000902^Respiratory rate (set)^ADM||96||||||F
OBX|272|TX|ReVE001001^Respiratory rate (total)^ADM||36||||||F
OBX|273|TX|ReVE001102^Tidal volume (set)^ADM||30||||||F
OBX|274|TX|ReVE001202^Tidal volume (effective)^ADM||56||||||F
OBX|275|TX|ReVE001501^Minute volume expired^ADM||6.00||||||F
OBX|276|TX|ReVE001803^Positive end expiratory pressure (PEEP)^ADM||23||||||F
OBX|277|TX|ReVE002102^Pressure support level^ADM||10||||||F
OBX|278|TX|ReVE002401^Mean airway pressure^ADM||2.0||||||F
OBX|279|TX|ReVE002801^Adult ventilation inspiratory time^ADM||3.00||||||F
OBX|280|TX|ReVE002900^Adult ventilation inspiratory:expiratory (I:E) ratio^ADM||I:E Ratio||||||F
OBX|281|TX|ReVE003500^Adult ventilation water bag check^ADM||Y||||||F
OBX|282|TX|ReVE004202^High inspiratory pressure alarm^ADM||29||||||F
OBX|283|TX|ReVE004301^Low inspiratory pressure alarm^ADM||18||||||F
OBX|284|TX|ReVE004601^Low minute volume alarm^ADM||99.00||||||F
OBX|285|TX|ReVE004800^Adult ventilation percent oxygen low^ADM||90||||||F
OBX|286|TX|ReVE005000^Adult ventilation apnea time^ADM||26||||||F
OBX|287|TX|ReVE005201^Adult ventilation end tidal carbon dioxide (CO2)^ADM||89.0||||||F
OBX|288|TX|ReVE007803^System type^ADM||system type||||||F
OBX|289|TX|ReVE008302^Inspiratory time^ADM||1.0||||||F
OBX|290|TX|ReVE008502^Patient leak^ADM||3||||||F
OBX|291|CE|ReVE009103^Ventilation medications salbutamol administration^ADM||2^100 mcg puff x 2||||||F
OBX|292|CE|ReVE009304^Ventilation medications ipratropium bromide admin^ADM||2^20 mcg puff x 2||||||F
OBX|293|TX|ReVE009310^Bronchodilators other^ADM||Broncho other||||||F
OBX|294|CE|ReVE009501^Adult ventilation medications fluticasone administration^ADM||2^250 mcg puff x 4||||||F
OBX|295|CE|ReVE009601^Adult ventilation medications budesonide administration^ADM||1^0.5 mg nebule||||||F
OBX|296|TX|ReVE009710^Inhaled corticosteroids other^ADM||inhaled steroid||||||F
OBX|297|CE|ReVE009807^Bronchodilators route of administration^ADM||1^Ventilator circuit||||||F
OBX|298|CE|ReVE009809^Corticosteroid route of administration^ADM||1^Ventilator circuit||||||F
OBX|299|CE|ReVE009811^Other medications route of administration^ADM||1^Nebulizer||||||F
OBX|300|TX|ReVE009830^Aerosolized medication other^ADM||aeor med other||||||F
OBX|301|TX|ReVE009900^Adult ventilation medications lidocaine 1% given ETT/trach^ADM||5.0||||||F
OBX|302|TX|ReVE010000^Adult ventilation medications lidocaine 4% given ETT/trach^ADM||5.0||||||F
OBX|303|TX|ReVE012101^FiO2 (set)^ADM||0.25||||||F
OBX|304|TX|ReVE012200^Adult ventilation fraction of inspired oxygen (measured)^ADM||0.36||||||F
OBX|305|TX|ReVE012400^Adult non-invasive vent fraction of inspired O2 (measured)^ADM||0.23||||||F
OBX|306|CE|ReVE012802^Non-invasive ventilation mode^ADM||6^Biphasic||||||F
OBX|307|TX|ReVEDATE01^Ventilator discontinuation date^ADM||20180216||||||F
OBX|308|TX|ReVENINI00^Date ventilation initiated^ADM||20180216||||||F
OBX|309|TX|ReVENTTI01^Ventilator discontinuation time^ADM||0930||||||F
OBX|310|CE|ReWRKBRE00^Work of breathing^ADM||3^Moderate||||||F
OBX|311|CE|VsBPDEUS00^Device used^ADM||2^Manual cuff||||||F
OBX|312|TX|VsBPDIAO03^Blood pressure diastolic^ADM||25||||||F
OBX|313|TX|VsBPSYSO03^Blood pressure systolic^ADM||125||||||F
OBX|314|TX|VsHRADLT04^Pulse rate^ADM||166||||||F
OBX|315|CE|VsHRMETH00^Heart rate method used^ADM||4^Monitor||||||F
OBX|316|TX|VsOXDRAD02^Oxygen therapy delivery rate^ADM||20||||||F
OBX|317|TX|VsPEW00000^Respiratory rate score^ADM||0||||||F
OBX|318|TX|VsPEW00100^Pulse rate PEWS score^ADM||3||||||F
OBX|319|CE|VsPEWBEM00^Bronchodilator every 15 minutes^ADM||1^Yes||||||F
OBX|320|CE|VsPEWCRT00^Capillary refill time^ADM||3^4 seconds||||||F
OBX|321|TX|VsPEWDBP10^Diastolic^ADM||80||||||F
OBX|322|CE|VsPEWPVS00^Persistent vomiting following surgery^ADM||2^No||||||F
OBX|323|CE|VsPEWSBE00^Behaviour^ADM||3^Decreased pain response||||||F
OBX|324|TX|VsPEWSBP10^Systolic^ADM||100||||||F
OBX|325|TX|VsPEWSCR00^Total PEWS score^ADM||11||||||F
OBX|326|TX|VsPEWSFC00^PEWS score for cardiovascular^ADM||3||||||F
OBX|327|CE|VsPEWSOD00^Supplemental oxygen delivered^ADM||4^> or = 8L or 60%||||||F
OBX|328|TX|VsPEWSPR10^Pulse rate^ADM||180||||||F
OBX|329|TX|VsPEWSRR10^Respiratory rate^ADM||30||||||F
OBX|330|TX|VsPEWSSB00^PEWS score for behaviour^ADM||3||||||F
OBX|331|CE|VsPEWSSC00^Skin colour^ADM||2^Pale||||||F
OBX|332|TX|VsPEWSSR00^PEWS score for respiratory^ADM||3||||||F
OBX|333|TX|VsPOONRA00^Pulse oximetry on room air^ADM||Y||||||F
OBX|334|TX|VsPOOSAD02^Pulse oximetry oxygen saturation^ADM||93||||||F
OBX|335|CE|VsPRBLOC00^Probe location^ADM||2^Hand||||||F
OBX|336|CE|VsPRLOMO00^Probe location modifier^ADM||1^Right||||||F
OBX|337|TX|VsRESPAD04^Respiratory rate^ADM||23||||||F
OBX|338|TX|VsVISICO00^Vital Signs comments^ADM||v/s comments||||||F
OBX|339|TX|zSEPSISM00^Sepsis screen^ADM||No Definite Risk||||||F
OBX|340|CE|zSEPSISM01^Sepsis action taken^ADM||5^APP previously notified||||||F
OBX|341|CE|zSEPSISM15^Infection criteria present^ADM||2^Documented infection||||||F
OBX|342|CE|zSEPSISM18^SIRS criteria present^ADM||3^RR > 20/min||||||F
OBX|343|CE|zSEPSISM19^Organ dysfunction criteria present^ADM||7^Serum CO2 < 20 mmol/L||||||F
OBX|344|TX|zSEPSISM43^Risk for sepsis identified^ADM||Y||||||F
OBX|345|TX|ADM WCB^IS THIS VISIT RELATED TO A WCB CLAIM?^INS||N||||||F
ZFD|OEDOCM^Oedoc^Marytrain^^^^MD^50003^DOC|9876 Main Street^^Surrey^BC^V3V 1Z1|||OEDOCN^Oedoc^Nancytrain^^^^MD^50005^DOC|OEDOCM^Oedoc^Marytrain^^^^MD^50003^DOC|
ZFH|LUMED||||||

MSH|^~\&|ADM|ARH|||201910211140||ADT^A03|4086873|D|2.2|||AL|NE
EVN|A03|201910211140||||201910211140
PID|1|FHATVIG0000337|AB00006671|AB6667|LABTEST^CGH^SPACE||19650101|F|||1212 WAY SIDE^^CHILLIWACK^BC^V2R 1E1|||||||AB000079/17|
PV1|1|I|AB-2BAKER^AB2B-B2117^1|UE|||OEDOCP^Oedoc^Petertrain^^^^MD^^^^^^XX|||MEDS||||||||IN||||||||||||||||||DISCHARGED TO ACUTE FACILITY|||ARH|||||201708310955|201910211140
PV2||P^Private - Non-Solicited|COPD
OBX|1|ST|1010.1^WEIGHT^CPT4||78.600||||||F
OBX|2|TX|ADM AC AUD^HIGH PROFILE PATIENT - ACCESS AUDIT (Y)^ADM||Y||||||F
OBX|3|CE|ADM CCI1^CCI#1^ADM||DNA^DNA-Do Not Acknowledge||||||F
OBX|4|TX|ADM CCI2^CCI#2^ADM||||||||F
OBX|5|TX|ADM CCI3^CCI#3^ADM||||||||F
OBX|6|TX|ADM CCI4^ARO - Antibiotic Resistant Organisms^ADM||||||||F
OBX|7|TX|ADM CCI5^DNA - Do Not Acknowledge^ADM||||||||F
OBX|8|TX|ADM CCI6^AVB - Aggressive/Violent Behaviour^ADM||||||||F
OBX|9|TX|ADM CCI7^MDR - Multiple Drug Resistant Organisms^ADM||||||||F
OBX|10|TX|ADM CCI7a^          **or**^ADM||||||||F
OBX|11|TX|ADM CCICO1^Comments:^ADM||||||||F
OBX|12|TX|ADM CCICO2^:^ADM||||||||F
OBX|13|TX|ADM CCICO3^:^ADM||||||||F
OBX|14|TX|ADM CURRES^Residing at current add. since (DD/MM/YY)^ADM||20151112||||||F
OBX|15|CE|ADM IDSOUR^SOURCE OF ID^ADM||BCSWP^BC Services With Photo||||||F
OBX|16|CE|ADM MDRO2^Canada in the last 12 months?^ADM||N^NO||||||F
OBX|17|CE|ADM MDRO4^or Bangladesh in the last 12 months?^ADM||Y^YES||||||F
OBX|18|CE|ADM MRSA2^correctional/shelter in the last 6 months?^ADM||N^NO||||||F
OBX|19|TX|AdADMDAT01^Admission date^ADM||20170801||||||F
OBX|20|TX|AdADMRSN00^Reason for admission^ADM||EXACERBATION OF COPD||||||F
OBX|21|TX|AdADMTIM00^Admission time^ADM||0920||||||F
OBX|22|TX|AdHCPDET00^Details of notification^ADM||I RECEIVED A REQUEST TO SEE AN END STAGE COPD PATIENT||||||F
OBX|23|TX|AdHCPNTM00^Notification method^ADM||REFERRAL||||||F
OBX|24|TX|AdHXCOND00^History of presenting condition^ADM||INCREASING SHORTNESS OF BREATH OVER PAST TWO WEEKS~INCREASING WHITE SPUTUM, IN PAST 3 DAYS SPUTUM HAS TURNED GREEN AND~PATIENT HAS BEEN FEBRILE.||||||F
OBX|25|TX|AdINFOTH00^Information source other^ADM||EHS||||||F
OBX|26|TX|CoAGICON00^Patient demonstrating agitation and/or confusion^ADM||Y||||||F
OBX|27|TX|HxCIGPH000^Tobacco use cigarette pack year history^ADM||20.00||||||F
OBX|28|TX|HxDSS00000^Tobacco use date stopped smoking^ADM||JNUE 2015||||||F
OBX|29|CE|HxHCDMAD01^Healthcare decision making advanced directives^ADM||2^Advance care plan||||||F
OBX|30|TX|HxHCDMAO01^Healthcare decision making advanced directives other^ADM||DNR||||||F
OBX|31|TX|HxNCIGD000^Tobacco use number of cigarettes per day^ADM||20||||||F
OBX|32|TX|HxNUMY0000^Tobacco use number of years^ADM||20||||||F
OBX|33|TX|HxOXADM002^History of home oxygen use^ADM||N||||||F
OBX|34|TX|HxPICUV001^Previous ICU admissions and/or ventilation^ADM||Y||||||F
OBX|35|TX|HxPRVSM000^Tobacco use previous smoker^ADM||Y||||||F
OBX|36|TX|HxSPTCHX00^Summary of patient's clinical history^ADM||ASTHMA AS A CHILD~SMOKING CIGARETTES 20 PACK YEARS~QUIT TWO YEARS AGO||||||F
OBX|37|TX|HxTABCU000^Tobacco use current use^ADM||Y||||||F
OBX|38|CE|HxTABTY000^Tobacco use type^ADM||1^Cigarettes||||||F
OBX|39|CE|MhDENTYP02^Type of dentures^ADM||1^Upper||||||F
OBX|40|CE|MhEYETYP02^Type of eyewear^ADM||2^Reading glasses||||||F
OBX|41|CE|MhHEATYP01^Type of hearing aids^ADM||3^Bilateral||||||F
OBX|42|CE|MhPBDEND01^Disposition of dentures^ADM||3^Kept/Sent with patient||||||F
OBX|43|CE|MhPBGLAD01^Disposition of eyewear^ADM||3^Kept/Sent with patient||||||F
OBX|44|CE|MhPBHEAD01^Disposition of hearing aids^ADM||2^Sent home||||||F
OBX|45|TX|MhPERAID01^Personal aids present^ADM||Y||||||F
OBX|46|CE|MoPOBDPO01^Bed position^ADM||3^Fowlers (45-60 deg)||||||F
OBX|47|CE|OECODESTAT^MOST Order Designation^ADM||DNR-M1^DNR - M1||||||F
OBX|48|TX|OhCPD00100^Designation of healthcare provider^ADM||RT AT THE MOMENT||||||F
OBX|49|CE|OhIN000300^Information source^ADM||1^Patient~7^Friend~15^Significant other||||||F
OBX|50|TX|OhNAMORG01^Name of organization or profession consulted^ADM||RESPIRATORY THERAPY||||||F
OBX|51|TX|OhPR000100^Name of healthcare provider^ADM||MARTHA KELLY||||||F
OBX|52|TX|ReAENTRY00^Air entry adequate throughout^ADM||N||||||F
OBX|53|CE|ReAUAIRE01^Air entry^ADM||4^Diminished||||||F
OBX|54|CE|ReAUBTHS02^Breath sounds^ADM||2^Wheezes||||||F
OBX|55|CE|ReAULOCT00^Auscultation location^ADM||7^Left lung||||||F
OBX|56|CE|ReAULOMO00^Auscultation location modifier^ADM||1^Anterior~2^Posterior||||||F
OBX|57|TX|ReBCLEAR00^Breath sounds clear throughout^ADM||N||||||F
OBX|58|CE|ReCGDESC01^Cough description^ADM||2^Congested||||||F
OBX|59|TX|ReCO000301^Oxygen saturation on room air^ADM||92||||||F
OBX|60|TX|ReCOPDCO00^COPD assessment general comments^ADM||REVIEW MEDICATIONS.~QUERY ANTIBIOTICS||||||F
OBX|61|CE|ReCOPDER03^COPD referrals^ADM||4^Pulmonary rehabilitation||||||F
OBX|62|TX|ReCPAPBI00^On home CPAP/BIPAP therapy^ADM||N||||||F
OBX|63|TX|ReDAPUFU00^Date of pulmonary function testing^ADM||20170301||||||F
OBX|64|TX|ReEXACPL01^Respiratory action plan in place^ADM||Y||||||F
OBX|65|TX|ReFRINOX01^Fraction of inspired oxygen (FiO2)^ADM||1.00||||||F
OBX|66|TX|ReLAEMVI02^Last FH emergency visit^ADM||JANUARY 2017||||||F
OBX|67|TX|ReMEDCON01^Controller inhalers used at home^ADM||ADVAIR 2 PUFFS BID||||||F
OBX|68|TX|ReMEDHOM02^Rescue inhalers used at home^ADM||VENTOLIN 2 PUFFS Q4H PRN||||||F
OBX|69|TX|ReOXHOFL02^Home oxygen flow rate^ADM||2||||||F
OBX|70|CE|ReOXYTHE04^Oxygen therapy delivery method^ADM||5^Nasal cannula||||||F
OBX|71|CE|RePHASE000^Phase^ADM||1^Inspiration||||||F
OBX|72|TX|ReREDISC00^Respiratory distress indicators comment^ADM||PHYSIO REFERAL||||||F
OBX|73|CE|ReREDISI00^Respiratory distress indicators^ADM||1^Accessory muscle use~2^Audible wheeze~4^Active exhalation||||||F
OBX|74|TX|ReREREPR00^Previous respiratory rehabilitation program attendance^ADM||Y||||||F
OBX|75|TX|ReRESPIR00^Currently followed by a respirologist^ADM||N||||||F
OBX|76|CE|ReSCAMNT00^Secretions amount^ADM||3^Moderate||||||F
OBX|77|CE|ReSCCOLR00^Secretions colour^ADM||7^Green||||||F
OBX|78|CE|ReSCDESC02^Secretions description^ADM||6^Purulent||||||F
OBX|79|TX|ReSLPDSW02^Difficulty with swallowing or signs of aspiration^ADM||Y||||||F
OBX|80|TX|ReSLPHSP00^History of recurrent pneumonia or COPD^ADM||Y||||||F
OBX|81|TX|ReSLPHWL00^History of significant weight loss^ADM||N||||||F
OBX|82|CE|ReSMCEIN03^Smoking cessation interventions offered^ADM||1^Not applicable||||||F
OBX|83|TX|ReSP000100^Spirometry referral completed by physician^ADM||Y||||||F
OBX|84|CE|ReWRKBRE00^Work of breathing^ADM||3^Moderate||||||F
OBX|85|TX|SpCOMRES00^Compliance with weight bearing/other restrictions^ADM||N||||||F
OBX|86|TX|SpSEFCAS00^Able to self monitor issues related to casting^ADM||N||||||F
OBX|87|TX|TeAD000100^Advised to see family physician one week post discharge^ADM||Y||||||F
OBX|88|CE|TeEDFURQ00^Education follow up required^ADM||2^Further instruction||||||F
OBX|89|CE|TeEDMATP00^Learning materials provided^ADM||1^Handout/Pamphlet~4^Online learning module||||||F
OBX|90|CE|TeEDMETH00^Education method^ADM||1^Discussion~3^Demonstration||||||F
OBX|91|CE|TeEDPRVD00^Education provided to^ADM||1^Patient~2^Spouse||||||F
OBX|92|CE|TeREDTOP00^COPD education topics^ADM||2^Breathing techniques||||||F
OBX|93|CE|VsBPCFLP01^Blood pressure cuff location^ADM||1^Right arm||||||F
OBX|94|TX|VsBPDIAO01^Blood pressure diastolic^ADM||50||||||F
OBX|95|TX|VsBPMAPA03^Blood pressure mean arterial pressure^ADM||42||||||F
OBX|96|CE|VsBPPOST02^Patient position^ADM||3^Sitting||||||F
OBX|97|TX|VsBPSYSO01^Blood pressure systolic^ADM||100||||||F
OBX|98|TX|VsHRADLT01^Heart rate^ADM||75||||||F
OBX|99|CE|VsHRLOCA02^Heart rate location^ADM||1^Radial||||||F
OBX|100|CE|VsHRLOMO00^Pulse location modifier^ADM||1^Right||||||F
OBX|101|CE|VsHRMETH00^Heart rate method used^ADM||1^Palpation||||||F
OBX|102|CE|VsHRRHYM02^Pulse rhythm^ADM||2^Irregular||||||F
OBX|103|TX|VsOXDRAD01^Oxygen therapy delivery rate^ADM||2||||||F
OBX|104|TX|VsPOOSAD00^Pulse oximetry oxygen saturation^ADM||91||||||F
OBX|105|CE|VsPRLOMO00^Probe location modifier^ADM||1^Right||||||F
OBX|106|CE|VsPROLOC00^Probe location^ADM||1^Finger||||||F
OBX|107|CE|VsPULSTR00^Pulse strength on palpation^ADM||1^Weak||||||F
OBX|108|TX|VsRESPAD00^Respiration rate^ADM||26||||||F
OBX|109|TX|VsRESPAD03^Respiratory rate^ADM||15||||||F
OBX|110|CE|VsTPSORC01^Temperature source^ADM||1^Oral||||||F
OBX|111|TX|VsTPTEMPO2^Temperature^ADM||39.0||||||F
OBX|112|TX|VsVISICO00^Vital Signs comments^ADM||PATIENT IS UNCOMFORTABLE||||||F
OBX|113|TX|VsWT000101^Current Weight^ADM||78.600||||||F
OBX|114|CE|VsWT000700^Weight measurement method^ADM||2^Bed scale||||||F
OBX|115|TX|VsWTGRAM00^Weight (Calculated Grams)^ADM||78600.000||||||F
OBX|116|TX|zSEPSISM00^Sepsis screen^ADM||Severe Sepsis Risk||||||F
OBX|117|CE|zSEPSISM01^Sepsis action taken^ADM||1^Physician notified||||||F
OBX|118|TX|zSEPSISM02^Name of provider notified^ADM||TEST||||||F
OBX|119|CE|zSEPSISM15^Infection criteria present^ADM||1^Suspected new infection||||||F
OBX|120|CE|zSEPSISM18^SIRS criteria present^ADM||1^Pulse > 90 bpm~2^Temp > 38C~8^Bands > 10%||||||F
OBX|121|CE|zSEPSISM19^Organ dysfunction criteria present^ADM||2^Creatinine > 2 mg/dl~5^Urine Output <0.5 ml/kg/h||||||F
OBX|122|TX|zSEPSISM43^Risk for sepsis identified^ADM||Y||||||F
OBX|123|TX|ADM WCB^IS THIS VISIT RELATED TO A WCB CLAIM?^INS||Y||||||F
ZFD|OEDOCM^Oedoc^Marytrain^^^^MD^50003^DOC|9876 Main Street^^Surrey^BC^V3V 1Z1|||OEDOCP^Oedoc^Petertrain^^^^MD^50004^DOC|OEDOCN^Oedoc^Nancytrain^^^^MD^50005^DOC|
ZFH|LUMED||||||

